NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Ownership - Who owns Alterity Therapeutics?

Insider buying vs selling

Have Alterity Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ATHE insiders and whales buy or sell their stock.

ATHE Shareholders

What type of owners hold Alterity Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Point72 Asset Management LP0.00%131,431$658.47kInstitution
Morgan Stanley0.00%58,301$292.09kInstitution
Greenleaf Trust0.00%17,000$85.17kInstitution
Bnp Paribas Financial Markets0.00%8,190$41.03kInstitution
Twin Lakes Capital Management LLC0.00%5,925$29.68kInstitution
Eversource Wealth Advisors LLC0.00%628$3.15kInstitution
Osaic Holdings Inc0.00%181$906.81Institution
Rhumbline Advisers0.00%130$651.30Institution
Blue Trust Inc0.00%40$200.40Institution
Steward Partners Investment Advisory LLC0.00%6$30.06Institution

1 of 2

ATHE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHE0.00%0.00%
SPRB9.69%90.31%Net SellingNet Selling
DOMH6.37%59.36%
ALXO54.30%28.14%Net BuyingNet Buying
VANI2.77%97.23%Net BuyingNet Buying

Alterity Therapeutics Stock Ownership FAQ

Who owns Alterity Therapeutics?

Alterity Therapeutics (NASDAQ: ATHE) is owned by 0.00% institutional shareholders, 0.00% Alterity Therapeutics insiders, and 100.00% retail investors. Point72 Asset Management LP is the largest individual Alterity Therapeutics shareholder, owning 131,431.00 shares representing 0.00% of the company. Point72 Asset Management LP's Alterity Therapeutics shares are currently valued at $634.81k.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.